LB Pharmaceuticals Inc (LBRX) Institutional Ownership & Insider Trading
115 institutions reported holding LB Pharmaceuticals Inc shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
LBRXLB Pharmaceuticals IncFollow LBRX — free
—
Price chart with a free account
- Market cap
- 1.2B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
Institutions · all 13F filers
quarter to 30 Jun 2026 · filers in both quarters115 institutions held 95.5% of the shares. Across filers that reported both quarters, shares held changed +9.2%.
Largest moves, shares (millions)
Institutional flow by quarter
net shares added or trimmed, millions · filers in both quarters| Quarter | Holders | Shares held, M | Change | Increased | New | Decreased | Closed |
|---|---|---|---|---|---|---|---|
| Jun 26 | 115 | 31 | +9.2% | 41 | 39 | 12 | 3 |
| Mar 26 | 77 | 28 | +14.5% | 30 | 16 | 14 | 9 |
| Dec 25 | 68 | 25 | +6.9% | 12 | 29 | 12 | 15 |
| Sep 25 | 53 | 21 | — | — | — | — | — |
LB Pharmaceuticals Inc — questions
- Who owns LB Pharmaceuticals Inc stock?
- 115 institutions reported LB Pharmaceuticals Inc shares in 13F filings for the quarter ended 2026-06-30. The largest: Deep Track Capital, LP (10.4%), BlackRock, Inc. (8.5%), RA CAPITAL MANAGEMENT, L.P. (6.8%).
Every figure on this page comes from LB Pharmaceuticals Inc's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.